Category: Diagnostic Technologies

Diagnostic Technologies

The U.S. Food and Drug Administration has cleared Nova Biomedical’s new blood glucose reference analyzer, Nova Primary.

BD and Magnolia Medical Technologies aim to help hospitals reduce blood culture contamination and improve testing accuracy.

The pandemic changed many aspects of American society, including the acceptance and prevalence of at-home testing.

Tuberculosis diagnosis usually requires coughing up a sputum sample from the lungs, but another way has been found to identify the disease.

Proscia has introduced the next version of its Concentriq Dx platform, which will help laboratories transition to 100% digital diagnosis.

Roche received 510(k) clearance from the FDA for the cobas pure integrated solutions, new to the cobas family of Serum Work Area solutions.

Flow cytometry labs are under pressure due to time, regulatory, and budgetary constraints, but there are ways to increase efficiency.

Beckman Coulter and Scopio Labs are partnering to accelerate adoption of Scopio's next generation peripheral blood smear platforms.

Siemens Healthineers' INNOVANCE VWF Ac fully-automated assay for Von Willebrand disease is now available to U.S. laboratories.

A retrospective study correlated blood adenosine levels to the development of complications or prematurity.

Karius is partnering with Capstone Health Alliance to streamline access to its test, which can rapidly detect more than 1,000 pathogens.

Genetic testing can diagnose cardiomyopathy in children and help detect who will have heart failure and require a transplant.

A new poll shows, 48% of people age 50 to 80 have bought at-home medical tests, including 32% who had bought COVID-19 tests.

Researchers have developed a smart diaper that measures multiple components in urine and can share those results over Bluetooth.